Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 225

1.

Designs of trials assessing interventions to improve the peer review process: a vignette-based survey.

Heim A, Ravaud P, Baron G, Boutron I.

BMC Med. 2018 Oct 15;16(1):191. doi: 10.1186/s12916-018-1167-7.

2.

Development and validation of a sensitive LC-MS/MS assay for the quantification of anserine in human plasma and urine and its application to pharmacokinetic study.

Everaert I, Baron G, Barbaresi S, Gilardoni E, Coppa C, Carini M, Vistoli G, Bex T, Stautemas J, Blancquaert L, Derave W, Aldini G, Regazzoni L.

Amino Acids. 2018 Oct 9. doi: 10.1007/s00726-018-2663-y. [Epub ahead of print]

PMID:
30302566
3.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2018 Aug 6. doi: 10.1002/cpt.1194. [Epub ahead of print]

PMID:
30079582
4.

Isotopic labelling for the characterisation of HNE-sequestering agents in plant-based extracts and its application for the identification of anthocyanidins in black rice with giant embryo.

Colzani M, Regazzoni L, Criscuolo A, Baron G, Carini M, Vistoli G, Lee YM, Han SI, Aldini G, Yeum KJ.

Free Radic Res. 2018 Aug;52(8):896-906. doi: 10.1080/10715762.2018.1490735. Epub 2018 Jul 23.

PMID:
30035649
5.

Determinants of influenza vaccination among a large adult population in Quebec.

Baron G, Gosselin V, Petit G, Guay M, Gagneur A.

Hum Vaccin Immunother. 2018 Jun 8:1-6. doi: 10.1080/21645515.2018.1486155. [Epub ahead of print]

PMID:
29883242
6.

N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why.

Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, Sergio F.

Free Radic Res. 2018 Jul;52(7):751-762. doi: 10.1080/10715762.2018.1468564. Epub 2018 May 9. Review.

PMID:
29742938
7.

Association between waist-to-height ratio and anxiety in middle-aged women: a secondary analysis of a cross-sectional multicenter Latin American study.

Arroyo KJ, Ramos-Torres G, Mezones-Holguin E, Blümel JE, Barón G, Bencosme A, Benítez Z, Bravo LM, Calle A, Flores D, Espinoza MT, Gómez G, Hernández-Bueno JA, Martino M, Lima S, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Sánchez H, Tserotas K, Vallejo MS, Witis S, Zúñiga MC, Chedraui P.

Menopause. 2018 Aug;25(8):904-911. doi: 10.1097/GME.0000000000001089.

PMID:
29509599
8.

Factors associated with online media attention to research: a cohort study of articles evaluating cancer treatments.

Haneef R, Ravaud P, Baron G, Ghosn L, Boutron I.

Res Integr Peer Rev. 2017 Jul 1;2:9. doi: 10.1186/s41073-017-0033-z. eCollection 2017.

9.

Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis.

Zeitoun JD, Ross JS, Atal I, Vivot A, Downing NS, Baron G, Ravaud P.

Clin Pharmacol Ther. 2018 Nov;104(5):1000-1007. doi: 10.1002/cpt.1038. Epub 2018 Feb 24.

PMID:
29377075
10.

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.

Zeitoun JD, Ross JS, Atal I, Vivot A, Downing NS, Baron G, Ravaud P.

BMJ Open. 2017 Dec 21;7(12):e018587. doi: 10.1136/bmjopen-2017-018587.

11.

Intensive spa and exercise therapy program for returning to work for low back pain patients: a randomized controlled trial.

Nguyen C, Boutron I, Rein C, Baron G, Sanchez K, Palazzo C, Dupeyron A, Tessier JM, Coudeyre E, Eschalier B, Forestier R, Roques-Latrille CF, Attal Y, Lefèvre-Colau MM, Rannou F, Poiraudeau S.

Sci Rep. 2017 Dec 20;7(1):17956. doi: 10.1038/s41598-017-18311-z.

12.

Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trials.

Haneef R, Yavchitz A, Ravaud P, Baron G, Oransky I, Schwitzer G, Boutron I.

BMJ Open. 2017 Nov 17;7(11):e017425. doi: 10.1136/bmjopen-2017-017425.

13.

Evolution of pain at 3 months by oral resveratrol in knee osteoarthritis (ARTHROL): protocol for a multicentre randomised double-blind placebo-controlled trial.

Nguyen C, Boutron I, Baron G, Coudeyre E, Berenbaum F, Poiraudeau S, Rannou F.

BMJ Open. 2017 Sep 29;7(9):e017652. doi: 10.1136/bmjopen-2017-017652.

14.

Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.

Morel J, Constantin A, Baron G, Dernis E, Flipo RM, Rist S, Combe B, Gottenberg JE, Schaeverbeke T, Soubrier M, Vittecoq O, Dougados M, Saraux A, Mariette X, Ravaud P, Sibilia J.

Rheumatology (Oxford). 2017 Oct 1;56(10):1746-1754. doi: 10.1093/rheumatology/kex238.

PMID:
28957557
15.

Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.

Zeitoun JD, Baron G, Vivot A, Atal I, Downing NS, Ross JS, Ravaud P.

Int J Cancer. 2018 Jan 15;142(2):414-423. doi: 10.1002/ijc.31061. Epub 2017 Oct 12.

PMID:
28929484
16.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Le Guern V, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Van Vollenhoven R, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2018 Jun;103(6):1074-1082. doi: 10.1002/cpt.885. Epub 2017 Nov 9.

PMID:
28925027
17.

Deconstructing Superorganisms and Societies to Address Big Questions in Biology.

Kennedy P, Baron G, Qiu B, Freitak D, Helanterä H, Hunt ER, Manfredini F, O'Shea-Wheller T, Patalano S, Pull CD, Sasaki T, Taylor D, Wyatt CDR, Sumner S.

Trends Ecol Evol. 2017 Nov;32(11):861-872. doi: 10.1016/j.tree.2017.08.004. Epub 2017 Sep 9. Review.

PMID:
28899581
18.

Management of oral bisphosphonates treatment by rheumatologists and determinants of therapeutic changes: a case-vignette-based study.

Roux C, Baron G, Briot K, Roux B, Cortet B, Thomas T.

Osteoporos Int. 2017 Dec;28(12):3339-3345. doi: 10.1007/s00198-017-4188-8. Epub 2017 Aug 29.

PMID:
28852785
19.

Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus.

Morel N, Lévesque K, Maltret A, Baron G, Hamidou M, Orquevaux P, Piette JC, Barriere F, Le Bidois J, Fermont L, Fain O, Theulin A, Sassolas F, Hauet Q, Guettrot-Imbert G, Georgin-Lavialle S, Deligny C, Hachulla E, Mouthon L, Le Jeunne C, Ravaud P, Le Mercier D, Romefort B, Villain E, Bonnet D, Costedoat-Chalumeau N; “Lupus néonatal” group.

Int J Cardiol. 2017 Dec 1;248:263-269. doi: 10.1016/j.ijcard.2017.07.100. Epub 2017 Aug 7.

PMID:
28843719
20.

Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.

Puéchal X, Pagnoux C, Baron G, Quémeneur T, Néel A, Agard C, Lifermann F, Liozon E, Ruivard M, Godmer P, Limal N, Mékinian A, Papo T, Ruppert AM, Bourgarit A, Bienvenu B, Geffray L, Saraux JL, Diot E, Crestani B, Delbrel X, Sailler L, Cohen P, Le Guern V, Terrier B, Groh M, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2017 Nov;69(11):2175-2186. doi: 10.1002/art.40205. Epub 2017 Oct 15.

Supplemental Content

Loading ...
Support Center